The Catholic University of Korea Cancer Research Institute
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Dasatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 02 Dec 2016 New trial record
Latest Information Update: 05 Nov 2021